Zanamivir controlled release - Ala Wai Pharma

Drug Profile

Zanamivir controlled release - Ala Wai Pharma

Alternative Names: AWP 09VDB S; Zanamivir gastric resistant - Ala Wai Pharma

Latest Information Update: 02 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ala Wai Pharma
  • Class Antivirals; Guanidines; Pyrans; Sialic acids
  • Mechanism of Action Neuraminidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Influenza virus infections

Most Recent Events

  • 02 Aug 2017 Chemical structure information added
  • 18 Oct 2016 Phase-I clinical trials in Influenza virus infections (In volunteers) in Australia (PO) (ACTRN12616001475437)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top